Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Transfer of Immunity Using Vaccinate and Boost Strategy with Bispecific Antibody Armed T Cells (BATs) in Metastatic Breast Cancer Patients

Archana Thakur, PhD, Joseph P. Uberti, MD, PhD, Voravit Ratanatharathorn, MD, Lawrence G. Lum, MD DSC

Blood (2016) 128 (22): 3459.

https://doi.org/10.1182/blood.V128.22.3459.3459

Published: 2016

Journal Articles

Incidence, Etiology and Outcome of Pleural Effusions in Patients Undergoing Allogeneic Stem Cell Transplantation

Dipenkumar Modi, MD, Abhinav Deol, MD, Divaya Bhutani, MD, Lawrence G. Lum, MD DSC, Lois Ayash, MD, Voravit Ratanatharathorn, MD, Hyejeong Jang, MS, Seongho Kim, PhD, Richard Manasa, B.S., Kendra Mellert, M.S.A.; C.C.R.P., Joseph P. Uberti, MD, PhD

Blood (2015) 126 (23): 5442.

https://doi.org/10.1182/blood.V126.23.5442.5442

Published: 2015

Journal Articles

Outcomes of Second Autologous Peripheral Blood Stem Cell Transplant in Multiple Myeloma Patients with Renal Dysfunction

Lakshminarayanan Nandagopal, MD, J. Christine Ye, MD MSc, Richard Manasa, BS, Muneer H. Abidi, MD, Lois Ayash, MD, Lawrence G Lum, MD DSc, Joseph P. Uberti, MD PhD, Voravit Ratanatharathorn, MD, Jeffrey Zonder, MD, Divaya Bhutani, MD, Abhinav Deol, MD

Blood (2014) 124 (21): 5894.

https://doi.org/10.1182/blood.V124.21.5894.5894

Published: 2014

Journal Articles

Influence of Race on Outcomes in Multiple Myeloma Patients with Renal Dysfunction Undergoing High Dose Therapy Followed By Autologous Stem Cell Transplant

Lakshminarayanan Nandagopal, MD, J. Christine Ye, MD MSc, Marie Ventimiglia, Muneer H. Abidi, MD, Lois Ayash, MD, Jeffrey Zonder, MD, Lawrence G Lum, MD DSc, Joseph P. Uberti, MD PhD, Voravit Ratanatharathorn, MD, Divaya Bhutani, MD, Abhinav Deol, MD

Blood (2014) 124 (21): 5904.

https://doi.org/10.1182/blood.V124.21.5904.5904

Published: 2014

Journal Articles

Outcomes in Patients on Hemodialysis Who Undergo High Dose Therapy Followed By Autologous Peripheral Blood Stem Cell Transplant for Multiple Myeloma in the Era of Novel Agents

J. Christine Ye, MD MSc, Lakshminarayanan Nandagopal, MD, Marie Ventimiglia, Muneer H. Abidi, MD, Lois Ayash, MD, Lawrence G Lum, MD DSc, Joseph P. Uberti, MD PhD, Voravit Ratanatharathorn, MD, Jeffrey Zonder, MD, Divaya Bhutani, MD, Abhinav Deol, MD

Blood (2014) 124 (21): 2518.

https://doi.org/10.1182/blood.V124.21.2518.2518

Published: 2014

Journal Articles

Incidence, Risk Factors and Outcome Of Cytomegalovirus (CMV) Viremia and CMV Gastroenteritis In Patients With Gastrointestinal Graft Versus Host Disease (GI GVHD)

Divaya Bhutani, MD, Gregory Dyson, MS, Richard Manasa, BS, Voravit Ratanatharathorn, MD, Abhinav Deol, MD, Muneer H. Abidi, MD, Zaid Al-Kadhimi, MD, Lois Ayash, MD, Lawrence G Lum, MD, DSc, Joseph P. Uberti, MD, PhD

Blood (2013) 122 (21): 2039.

https://doi.org/10.1182/blood.V122.21.2039.2039

Published: 2013

Journal Articles

Antithymocyte Globulin (Rabbit) Enhanced The Efficacy Of Tacrolimus and Mycophenolate For Graft-Versus-Host Disease Prophylaxis In Recipients Of Unrelated Stem Cell Transplant Resulting In Improvement Of Survival

Voravit Ratanatharathorn, MD, Abhinav Deol, MD, Lois Ayash, MD, Divaya Bhutani, MD, Lawrence G Lum, MD, DSc, Zaid Al-Kadhimi, MD, Muneer H. Abidi, MD, Marie Ventimiglia, Kendra Mellert, Joseph P. Uberti, MD, PhD

Blood (2013) 122 (21): 3300.

https://doi.org/10.1182/blood.V122.21.3300.3300

Published: 2013

Journal Articles

Low Incidence Of Severe Cgvhd and Late NRM In a Phase II Trial Of Thymoglobulin®, Tacrolimus and Sirolimus For Gvhd Prevention

Zaid Al-Kadhimi, MD, Alireza Eghtedar, MD, Zartash Gul, MD, Wei Chen, PhD, Daryn Smith, Abhinav Deol, MD, Muneer H. Abidi, MD, Lawrence G Lum, MD, DSc, Divaya Bhutani, MD, Lois Ayash, MD, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD

Blood (2013) 122 (21): 5471.

https://doi.org/10.1182/blood.V122.21.5471.5471

Published: 2013

Journal Articles

Induction Of Anti-Myeloma Cellular and Humoral Immunity By Pre-Targeting Clonogenic Myeloma Cells Prior To Stem Cell Transplant With T Cells Armed With Anti-CD3 x Anti-CD20 Bispecific Antibody Leads To Transfer Of Cellular and Humoral Anti-Myeloma Immunity

Lawrence G Lum, MD, DSc, Archana Thakur, PhD, Zaid Al-Kadhimi, MD, Abhinav Deol, MBBS, MD, Lois Ayash, MD, Elyse N. Tomaszewski, BA, Hiroshi Yano, BS, Dana L Schalk, BS, MBA, Sri Vidya Kondadasula, MS, Patricia A. Steele, RN, BSN, Jeffrey A. Zonder, MD, Joseph P. Uberti, MD, PhD, Voravit Ratanatharathorn, MD, Muneer H. Abidi, MD

Blood (2013) 122 (21): 139.

https://doi.org/10.1182/blood.V122.21.139.139

Published: 2013

Journal Articles

High Rates of Severe aGVHD with Tacrolimus and Mycophenolate Mofetil in a Large Cohort of Related and Unrelated Allogeneic Transplant Patients

Zaid Al-Kadhimi, MD, Zartash Gul, MD, Wei Chen, PhD, Daryn Smith, Abhinav Deol, MD, Muneer H. Abidi, MD, Lois Ayash, MD, Lawrence G Lum, MD, DSc, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD

Blood (2012) 120 (21): 1951.

https://doi.org/10.1182/blood.V120.21.1951.1951

Published: 2012

Journal Articles

Successful Hematopoietic Stem Cells (HSC) Mobilization in Patients Who Fail Plerixafor Mobilization for Autologous Stem Cells Transplant (ASCT)

Tania Jain, MD, Muthu Veeraputhiran, MD, Simon Cronin, Pharm, D, Zaid Al-Kadhimi, MD, Muneer H. Abidi, MD, Lois Ayash, MD, Voravit Ratanatharathorn, MD, Lawrence G Lum, MD, DSc, Joseph P. Uberti, MD, PhD, Abhinav Deol, MD

Blood (2012) 120 (21): 1913.

https://doi.org/10.1182/blood.V120.21.1913.1913

Published: 2012

Journal Articles

Transfer of Cellular and Humoral Anti-Tumor Immunity with Immune T Cells After Stem Cell Transplant (SCT) for Metastatic Breast Cancer Following “Vaccination” with Anti-CD3 x Anti-Her2/Neu Bispecific Antibody (Her2Bi) Armed Activated T Cells

Archana Thakur, PhD, Zaid Al-Kadhimi, MD, Cassara Pray, BS, Elyse N. Tomaszewski, BA, Ritesh Rathore, MD, Patricia A. Steele, RN, BSN, Muneer H. Abidi, MD, Lois Ayash, MD, Dana L Schalk, BS, MBA, Karen Myers, BSN, OCN, Alice Mitchell, BS, Abhinav Deol, MD, Joseph P. Uberti, MD, PhD, Voravit Ratanatharathorn, MD, Lawrence G Lum, MD, DSc

Blood (2011) 118 (21): 1914.

https://doi.org/10.1182/blood.V118.21.1914.1914

Published: 2011

Journal Articles

Use of Plerixafor to Overcome Stem Cell Mobilization Failure: Long Term Follow up of Patients Proceeding to Transplant Using Plerixafor Mobilized Stem Cells

Abhinav Deol, MD, Judith Abrams, PhD, Ashiq Masood, MD, Zaid Al-Kadhimi, MD, Muneer H. Abidi, MD, Lois Ayash, MD, Voravit Ratanatharathorn, MD, Lawrence G Lum, MD, DSc, Joseph P. Uberti, MD, PhD

Blood (2011) 118 (21): 4390.

https://doi.org/10.1182/blood.V118.21.4390.4390

Published: 2011

Journal Articles

A Prospective Phase II Trial: The Combination of Tacrolimus, Sirolimus, and Rabbit Anti-Thymocyte Globulin (Thymoglobulin® Thymo) to Prevent Acute Graft Vs. Host Disease (aGVHD) in Patients Receiving Unrelated Hematopoietic Stem Cell Transplantation (UHSCT)

Zaid Al-Kadhimi, MD, Zartash Gul, MD, Roberto Rodriguez, MD, Wei Chen, PhD, Alice Mitchell, BS, Muneer H. Abidi, MD, Lois Ayash, MD, Abhinav Deol, MD, Lawrence G Lum, MD, DSc, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD

Blood (2011) 118 (21): 4551.

https://doi.org/10.1182/blood.V118.21.4551.4551

Published: 2011

Journal Articles

Phase I Dose Esclation of Activated T Cells (ATC) Armed with Anti-CD3 × Anti-CD20 Bispecific Antibody (CD20Bi) after Stem Cell Transplant (SCT) In Non-Hodgkin's Lymphoma (NHL)

Lawrence G. Lum, MD, DSc, Voravit Ratanatharathorn, MD, Archana Thakur, PhD, Zaid Al-Kadhimi, MD, Cassara Skuba, BS, Elyse N. Paul, BA, Patricia A. Steele, RN, BSN, Lois Ayash, MD, Muneer H. Abidi, MD, Joseph P. Uberti, MD, PhD

Blood (2010) 116 (21): 488.

https://doi.org/10.1182/blood.V116.21.488.488

Published: 2010

Journal Articles

Cytoprotective Palifermin Allowed Melphalan Dose Escalation to 280mg/ 2 for Multiple Myeloma Patients with Normal Renal Function Receiving Autologous Stem Cell Transplantation (ASCT) - Final Results of a Phase 1 Trial

Muneer H. Abidi, MD, Nishant Tageja, MD, Lawrence G. Lum, MD, DSC, Judith Abrams, Zaid Al-Kadhimi, Lois Ayash, Simon Cronin, Pharm, D, Marie Ventimiglia, Abhinav Deol, MBBS, MD, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD

Blood (2010) 116 (21): 2401.

https://doi.org/10.1182/blood.V116.21.2401.2401

Published: 2010

Journal Articles

Comparison of Clinical Outcomes and Day 30 Lymphocyte Recovery Between Two aGVHD Prophylaxis Regimens In Matched Unrelated Hematopoietic Stem Cell Transplant (MUD) Patients

Zartash Gul, MD, Mustafa Abdul-Hussein, MD, Ivo Ditah, MD, Joseph P. Uberti, MD, PhD, Muneer H. Abidi, MD, Lois Ayash, MD, Lawrence G. Lum, MD, DSC, Voravit Ratanatharathorn, MD, Zaid Al-Kadhimi, MD

Blood (2010) 116 (21): 2340.

https://doi.org/10.1182/blood.V116.21.2340.2340

Published: 2010

Journal Articles

A Phase I Study of Bortezomib During Maintenance Phase After High-Dose Melphalan and Autologous Stem Cell Transplantation In Patients with Multiple Myeloma

Muneer H. Abidi, MD, Zartash Gul, MD, Lawrence G. Lum, MD, DSC, Judith Abrams, Simon Cronin, Pharm, D, Marie Ventimiglia, Abhinav Deol, MBBS, MD, Lois Ayash, Zaid Al-Kadhimi, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD

Blood (2010) 116 (21): 2387.

https://doi.org/10.1182/blood.V116.21.2387.2387

Published: 2010

Journal Articles

The Combination of Tacrolimus (T), Sirolimus (S), and Rabbit Anti-Thymocyte Globulin (Thymoglobulin Thymo) to Prevent Acute Graft-Vs-Host Disease (aGVHD) in Patients (pts) Receiving Unrelated Hematopoietic Stem Cell Transplantation (UHSCT).

Zaid S Al-Kadhimi, M.D, Zartash Gul, MD, Lawrence G. Lum, MD, DSC, Lois Ayash, MD, Muneer H. Abidi, MD, Wei Chen, PhD, Alice Mitchell, BS, Voravit Ratanatharathorn, M.D, Joseph Uberti, M.D., Ph.D

Blood (2009) 114 (22): 2239.

https://doi.org/10.1182/blood.V114.22.2239.2239

Published: 2009

Journal Articles

T-Cell Large Granular Lymphocyte (T-LGL) Expansion Post Adult Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) – ‘A Prognostic Indicator for Improved Overall Survival’.

Mayur S Ramesh, MD, Zaid Al-Kadhimi, MD, Stephanie Mellon-Reppens, NP, Jason Valent, MD, Lawrence G Lum, MD, DSc, Lois Ayash, MD, Muneer H Abidi, MD, Voravit Ratanatharathorn, MD, Joseph Uberti, MD, PhD

Blood (2009) 114 (22): 2241.

https://doi.org/10.1182/blood.V114.22.2241.2241

Published: 2009

NARROW

Transfer of Immunity Using Vaccinate and Boost Strategy with Bispecific Antibody Armed T Cells (BATs) in Metastatic Breast Cancer Patients

Incidence, Etiology and Outcome of Pleural Effusions in Patients Undergoing Allogeneic Stem Cell Transplantation

Outcomes of Second Autologous Peripheral Blood Stem Cell Transplant in Multiple Myeloma Patients with Renal Dysfunction

Influence of Race on Outcomes in Multiple Myeloma Patients with Renal Dysfunction Undergoing High Dose Therapy Followed By Autologous Stem Cell Transplant

Outcomes in Patients on Hemodialysis Who Undergo High Dose Therapy Followed By Autologous Peripheral Blood Stem Cell Transplant for Multiple Myeloma in the Era of Novel Agents

Incidence, Risk Factors and Outcome Of Cytomegalovirus (CMV) Viremia and CMV Gastroenteritis In Patients With Gastrointestinal Graft Versus Host Disease (GI GVHD)

Antithymocyte Globulin (Rabbit) Enhanced The Efficacy Of Tacrolimus and Mycophenolate For Graft-Versus-Host Disease Prophylaxis In Recipients Of Unrelated Stem Cell Transplant Resulting In Improvement Of Survival

Low Incidence Of Severe Cgvhd and Late NRM In a Phase II Trial Of Thymoglobulin®, Tacrolimus and Sirolimus For Gvhd Prevention

Induction Of Anti-Myeloma Cellular and Humoral Immunity By Pre-Targeting Clonogenic Myeloma Cells Prior To Stem Cell Transplant With T Cells Armed With Anti-CD3 x Anti-CD20 Bispecific Antibody Leads To Transfer Of Cellular and Humoral Anti-Myeloma Immunity

High Rates of Severe aGVHD with Tacrolimus and Mycophenolate Mofetil in a Large Cohort of Related and Unrelated Allogeneic Transplant Patients

Successful Hematopoietic Stem Cells (HSC) Mobilization in Patients Who Fail Plerixafor Mobilization for Autologous Stem Cells Transplant (ASCT)

Transfer of Cellular and Humoral Anti-Tumor Immunity with Immune T Cells After Stem Cell Transplant (SCT) for Metastatic Breast Cancer Following “Vaccination” with Anti-CD3 x Anti-Her2/Neu Bispecific Antibody (Her2Bi) Armed Activated T Cells

Use of Plerixafor to Overcome Stem Cell Mobilization Failure: Long Term Follow up of Patients Proceeding to Transplant Using Plerixafor Mobilized Stem Cells

A Prospective Phase II Trial: The Combination of Tacrolimus, Sirolimus, and Rabbit Anti-Thymocyte Globulin (Thymoglobulin® Thymo) to Prevent Acute Graft Vs. Host Disease (aGVHD) in Patients Receiving Unrelated Hematopoietic Stem Cell Transplantation (UHSCT)

Phase I Dose Esclation of Activated T Cells (ATC) Armed with Anti-CD3 × Anti-CD20 Bispecific Antibody (CD20Bi) after Stem Cell Transplant (SCT) In Non-Hodgkin's Lymphoma (NHL)

Cytoprotective Palifermin Allowed Melphalan Dose Escalation to 280mg/ 2 for Multiple Myeloma Patients with Normal Renal Function Receiving Autologous Stem Cell Transplantation (ASCT) - Final Results of a Phase 1 Trial

Comparison of Clinical Outcomes and Day 30 Lymphocyte Recovery Between Two aGVHD Prophylaxis Regimens In Matched Unrelated Hematopoietic Stem Cell Transplant (MUD) Patients

A Phase I Study of Bortezomib During Maintenance Phase After High-Dose Melphalan and Autologous Stem Cell Transplantation In Patients with Multiple Myeloma

The Combination of Tacrolimus (T), Sirolimus (S), and Rabbit Anti-Thymocyte Globulin (Thymoglobulin Thymo) to Prevent Acute Graft-Vs-Host Disease (aGVHD) in Patients (pts) Receiving Unrelated Hematopoietic Stem Cell Transplantation (UHSCT).

T-Cell Large Granular Lymphocyte (T-LGL) Expansion Post Adult Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) – ‘A Prognostic Indicator for Improved Overall Survival’.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only